Abstract:The renal secretory clearance for organic cations (neurotransmitters, metabolism products and drugs) is mediated by transporters specifically expressed in the basolateral and apical plasma membrane domains of proximal tubule cells. Here, human organic cation transporter 2 (hOCT2) is the main transporter for organic cations in the basolateral membrane domain. In this study, we stably expressed hOCT2 in Madin-Darby Canine Kidney (MDCK) cells and cultivated these cells in the presence of an extracellular matrix t… Show more
“…A similar activating effect of AII on transport mediated by OCT was observed in freshly isolated renal mouse proximal tubules [ 51 ]. Using other experimental setups, for example, human embryonic kidney cells stably overexpressing hOCT2, such regulation by AII was not observed ( Supplementary Figure S1 ), probably due to the fact that these cells do not express AT1R endogenously or because regulation pathways can be different in strongly polarized cells, such as the MDCK cells [ 26 ]. In this study, AII stimulation of hOCT2 activity increased CDDP cellular toxicity and, therefore, may be also involved in the development of CDDP-induced nephrotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…The inhibition of OCT2 by substances such as cimetidine and pantoprazole may represent a useful approach to protect cells against undesired toxicity caused by Platinum agents [ 14 , 18 , 19 , 20 , 21 , 22 , 23 ] since cancer cells seem to express no or only low levels of this transporter [ 14 ]. Interestingly, the activity of OCT2 can be rapidly regulated by several signaling pathways [ 24 , 25 , 26 ] and by pathological states [ 27 , 28 , 29 ], suggesting a possible role of transporter regulation for modulating side effects of chemotherapy with Platinum agents. The hOCT2 regulation can be dependent on cell polarization [ 26 ], that is the formation of distinct apical and basolateral membrane domains, which is typical for renal epithelial cells.…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, the activity of OCT2 can be rapidly regulated by several signaling pathways [ 24 , 25 , 26 ] and by pathological states [ 27 , 28 , 29 ], suggesting a possible role of transporter regulation for modulating side effects of chemotherapy with Platinum agents. The hOCT2 regulation can be dependent on cell polarization [ 26 ], that is the formation of distinct apical and basolateral membrane domains, which is typical for renal epithelial cells.…”
Cisplatin (CDDP) is an efficient chemotherapeutic drug, whose use is associated with the development of serious undesired toxicities, such as nephrotoxicity. The human organic cation transporter 2 (hOCT2), which is highly expressed in the basolateral membrane domain of renal proximal tubules seems to play an important role in the development of CDDP nephrotoxicity. The role of angiotensin II (AII) signaling by binding to the AII receptor type 1 (AT1R) in the development and/or progression of CDDP nephrotoxicity is debated. Therefore, in this work, the regulation of hOCT2 activity by AII and its role in the development of CDDP cellular toxicity was investigated. To do this, hOCT2 was overexpressed by viral transduction in Madin–Darby Canine Kidney (MDCK) cells which were cultivated on a filter. This approach allows the separation of an apical and a basolateral membrane domain, which are easily accessible for experimentation. In this system, hOCT2 was mainly localized on the basolateral plasma membrane domain of the cells. The transporter was functional since a specific uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP+) with an affinity (Km) of 35 µM was only detectable by the addition of ASP+ to the basolateral compartment of hOCT2 expressing MDCK (hOCT2-MDCK) cells. Similarly, CDDP toxicity was evident mainly by CDDP addition to the basolateral compartment of hOCT2-MDCK cells cultivated on a filter. The addition of 1 nM AII stimulated hOCT2 function via PKC activation and worsened CDDP cytotoxicity via binding to AT1R. Therefore, the AII signaling pathway may be implicated in the development and/or progression of CDDP nephrotoxicity. This signaling pathway may be a target for protective interventions for example by blocking AT1R in the kidneys. However, it should be further investigated whether these findings obtained in a cell culture system may have translational relevance for the clinical situation. For toxicity experiments, a 100 µM CDDP concentration was used, which is high but allows us to identify clearly toxic effects due to hOCT2. In summary, down-regulation of hOCT2 activity by the inhibition of the AII signaling pathway may protect against CDDP nephrotoxicity.
“…A similar activating effect of AII on transport mediated by OCT was observed in freshly isolated renal mouse proximal tubules [ 51 ]. Using other experimental setups, for example, human embryonic kidney cells stably overexpressing hOCT2, such regulation by AII was not observed ( Supplementary Figure S1 ), probably due to the fact that these cells do not express AT1R endogenously or because regulation pathways can be different in strongly polarized cells, such as the MDCK cells [ 26 ]. In this study, AII stimulation of hOCT2 activity increased CDDP cellular toxicity and, therefore, may be also involved in the development of CDDP-induced nephrotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…The inhibition of OCT2 by substances such as cimetidine and pantoprazole may represent a useful approach to protect cells against undesired toxicity caused by Platinum agents [ 14 , 18 , 19 , 20 , 21 , 22 , 23 ] since cancer cells seem to express no or only low levels of this transporter [ 14 ]. Interestingly, the activity of OCT2 can be rapidly regulated by several signaling pathways [ 24 , 25 , 26 ] and by pathological states [ 27 , 28 , 29 ], suggesting a possible role of transporter regulation for modulating side effects of chemotherapy with Platinum agents. The hOCT2 regulation can be dependent on cell polarization [ 26 ], that is the formation of distinct apical and basolateral membrane domains, which is typical for renal epithelial cells.…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, the activity of OCT2 can be rapidly regulated by several signaling pathways [ 24 , 25 , 26 ] and by pathological states [ 27 , 28 , 29 ], suggesting a possible role of transporter regulation for modulating side effects of chemotherapy with Platinum agents. The hOCT2 regulation can be dependent on cell polarization [ 26 ], that is the formation of distinct apical and basolateral membrane domains, which is typical for renal epithelial cells.…”
Cisplatin (CDDP) is an efficient chemotherapeutic drug, whose use is associated with the development of serious undesired toxicities, such as nephrotoxicity. The human organic cation transporter 2 (hOCT2), which is highly expressed in the basolateral membrane domain of renal proximal tubules seems to play an important role in the development of CDDP nephrotoxicity. The role of angiotensin II (AII) signaling by binding to the AII receptor type 1 (AT1R) in the development and/or progression of CDDP nephrotoxicity is debated. Therefore, in this work, the regulation of hOCT2 activity by AII and its role in the development of CDDP cellular toxicity was investigated. To do this, hOCT2 was overexpressed by viral transduction in Madin–Darby Canine Kidney (MDCK) cells which were cultivated on a filter. This approach allows the separation of an apical and a basolateral membrane domain, which are easily accessible for experimentation. In this system, hOCT2 was mainly localized on the basolateral plasma membrane domain of the cells. The transporter was functional since a specific uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP+) with an affinity (Km) of 35 µM was only detectable by the addition of ASP+ to the basolateral compartment of hOCT2 expressing MDCK (hOCT2-MDCK) cells. Similarly, CDDP toxicity was evident mainly by CDDP addition to the basolateral compartment of hOCT2-MDCK cells cultivated on a filter. The addition of 1 nM AII stimulated hOCT2 function via PKC activation and worsened CDDP cytotoxicity via binding to AT1R. Therefore, the AII signaling pathway may be implicated in the development and/or progression of CDDP nephrotoxicity. This signaling pathway may be a target for protective interventions for example by blocking AT1R in the kidneys. However, it should be further investigated whether these findings obtained in a cell culture system may have translational relevance for the clinical situation. For toxicity experiments, a 100 µM CDDP concentration was used, which is high but allows us to identify clearly toxic effects due to hOCT2. In summary, down-regulation of hOCT2 activity by the inhibition of the AII signaling pathway may protect against CDDP nephrotoxicity.
“…The chemical structures of the OCT2 substrates are indicated in Figure S2 . The fluorescent dye DiASP, used here as a reference tracer substrate for OCT2 [ 59 , 60 ], was purchased from Invitrogen (Carlsbad, CA, USA).…”
The search of substrates for solute carriers (SLCs) constitutes a major issue, owing notably to the role played by some SLCs, such as the renal electrogenic organic cation transporter (OCT) 2 (SLC22A2), in pharmacokinetics, drug–drug interactions and drug toxicity. For this purpose, substrates have been proposed to be identified by their cis-inhibition and trans-stimulation properties towards transporter activity. To get insights on the sensitivity of this approach for identifying SLC substrates, 15 various exogenous and endogenous OCT2 substrates were analysed in the present study, using 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (DiASP) as a fluorescent OCT2 tracer substrate. All OCT2 substrates cis-inhibited DiASP uptake in OCT2-overexpressing HEK293 cells, with IC50 values ranging from 0.24 µM (for ipratropium) to 2.39 mM (for dopamine). By contrast, only 4/15 substrates, i.e., acetylcholine, agmatine, choline and metformin, trans-stimulated DiASP uptake, with a full suppression of the trans-stimulating effect of metformin by the reference OCT2 inhibitor amitriptyline. An analysis of molecular descriptors next indicated that trans-stimulating OCT2 substrates exhibit lower molecular weight, volume, polarizability and lipophilicity than non-trans-stimulating counterparts. Overall, these data indicated a rather low sensitivity (26.7%) of the trans-stimulation assay for identifying OCT2 substrates, and caution with respect to the use of such assay may therefore be considered.
“…In epithelial tissues, organic cation transporters show a polar distribution, being mainly localized in the basolateral plasma membrane domain. Therefore, Koepp et al [ 5 ] in their work “Properties of Transport Mediated by the Human Organic Cation Transporter 2 Studied in a Polarized Three-Dimensional Epithelial Cell Culture Model” stably expressed hOCT2 in Madin-Darby Canine Kidney (MDCK) cells and cultivated these cells in the presence of an extracellular matrix to obtain three-dimensional (3D) structures (cysts). In this system, hOCT2 showed a specific localization in the basolateral membrane domain.…”
This editorial summarizes the 12 scientific papers published in the Special Issue “Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations 2 [...]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.